| |
| |
|
| Insider
Information: |
Lloyd-Smith Malcolm |
| Relationship: |
Chief Integration Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
42,337 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,787,468 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,337 |
|
|
| Total
Value |
$5,787,468 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
SVP, Reg Affairs, Qual... |
2014-03-19 |
0 |
|
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Chief Integration Offi... |
2023-02-08 |
42,337 |
2016-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & ClinO |
• – – |
2012-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,332 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-02-07 |
4 |
AS |
$44.61 |
$5,175 |
D/D |
(116) |
1,082 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2022-02-08 |
4 |
AS |
$79.53 |
$55,751 |
D/D |
(701) |
18,731 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
• – – |
2023-02-08 |
4 |
AS |
$103.83 |
$72,785 |
D/D |
(701) |
42,337 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-02-06 |
4 |
AS |
$43.15 |
$31,370 |
D/D |
(727) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
• – – |
2023-02-06 |
4 |
AS |
$105.82 |
$84,758 |
D/D |
(801) |
29,300 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-02-05 |
4 |
AS |
$114.15 |
$98,739 |
D/D |
(865) |
29,675 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2019-02-06 |
4 |
AS |
$83.58 |
$76,894 |
D/D |
(920) |
19,238 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2018-02-05 |
4 |
AS |
$83.19 |
$79,863 |
D/D |
(960) |
13,982 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-02-07 |
4 |
AS |
$103.28 |
$104,827 |
D/D |
(1,015) |
23,200 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-01-26 |
4 |
AS |
$119.96 |
$131,965 |
D/D |
(1,100) |
29,002 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-01-26 |
4 |
OE |
$35.99 |
$39,589 |
D/D |
1,100 |
29,602 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2019-02-05 |
4 |
AS |
$88.13 |
$112,119 |
D/D |
(1,272) |
17,508 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2018-02-06 |
4 |
D |
$82.48 |
$108,379 |
D/D |
(1,314) |
15,318 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-02-06 |
4 |
AS |
$101.52 |
$151,258 |
D/D |
(1,490) |
22,287 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
• – – |
2023-01-31 |
4 |
AS |
$110.02 |
$183,290 |
D/D |
(1,666) |
28,582 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-02-10 |
4 |
OE |
$35.99 |
$61,183 |
D/D |
1,700 |
33,110 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-02-10 |
4 |
AS |
$119.95 |
$203,926 |
D/D |
(1,700) |
32,510 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-04-24 |
4 |
AS |
$99.45 |
$192,329 |
D/D |
(1,934) |
24,941 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-02-05 |
4 |
AS |
$103.03 |
$200,733 |
D/D |
(1,948) |
21,127 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-08-05 |
4 |
AS |
$118.86 |
$268,277 |
D/D |
(2,257) |
26,971 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-11-12 |
4 |
AS |
$90.73 |
$204,776 |
D/D |
(2,257) |
29,002 |
0 |
% |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
• – – |
2014-03-19 |
4 |
D |
$14.00 |
$32,648 |
D/D |
(2,332) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2022-02-07 |
4 |
AS |
$80.65 |
$216,417 |
D/D |
(2,681) |
18,104 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-02-08 |
4 |
AS |
$116.74 |
$380,929 |
D/D |
(3,261) |
32,510 |
0 |
% |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
